share_log

Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate

Surface Oncology Q2 EPS $(0.46) Misses $(0.34) Estimate

Surface Oncology 第二季度每股收益 (0.46) 低于预期 (0.34)
Benzinga ·  2023/08/02 07:15

Surface Oncology (NASDAQ:SURF) reported quarterly losses of $(0.46) per share which missed the analyst consensus estimate of $(0.34) by 35.29 percent. This is unchanged from the same period last year.

Surface Oncology(纳斯达克股票代码:SURF)公布的季度每股亏损为0.46美元,比分析师共识估计的0.34美元(0.34美元)低35.29%。这与去年同期相比没有变化。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发